Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of standard versus intensified interferon alfa-2b after radical surgery for stage III melanoma
ISRCTN75125874Phase 3Completed
- Sponsor
- Intergruppo Melanoma Italiano
- Start
- Nov 1998
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of interferon alfa-2b in cutaneous melanoma (CM) (2 arms), sponsored by Intergruppo Melanoma Italiano. Primary endpoint: Overall survival. Started Nov 1998; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on ISRCTN75125874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75125874.